BUY Dr. Lal Path Labs Ltd. — IDBI Capital
byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))30 Oct 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·19 Aug · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dr. Lal Path Labs
- BUY — Axis Securities12 Oct 2026 · ~1 year · target ₹2,315 · Active
- BUY — Kush Bohra9 Oct 2026 · Next day · target ₹1,990 · Target hit
- BUY — Deven Mehata, IDBI Capital Markets and Securities5 Oct 2026 · ~2 weeks · target ₹2,165 · SL hit
- BUY — Sachin Gupta5 Oct 2026 · ~2 weeks · target ₹2,100 · SL hit
- BUY — IDBI Capital1 Oct 2026 · ~3 months · target ₹2,195 · SL hit
More from IDBI Capital
- BUY Zensar Technologies30 Oct 2026 · ~2 weeks · target ₹590 · Active
- BUY ICICI Bank30 Oct 2026 · Same day · target ₹1,442.5 · Expired
- BUY Tech Mahindra30 Oct 2026 · ~2 weeks · target ₹1,852 · Active
- BUY Indegene30 Oct 2026 · ~1 year · target ₹685 · Active
- BUY One 97 Communications29 Oct 2026 · ~3 months · target ₹1,832 · Active

